About other rarer BCR-partner fusion genes, such as t(8;22) BCR/FGFR1, which confer to ALL a particularly aggressive disease course and dismal outcome, a standardized methods for MRD detection is lacking and response monitoring is usually performed with cytogenetic techniques or qualitative PCR [66]. Here, BCR is linked to acute lymphoblastic leukemia.